Nathan Weinstein
Stock Analyst at Aegis Capital
(0.26)
# 4,306
Out of 4,996 analysts
61
Total ratings
13.33%
Success rate
-26.26%
Average return
Main Sectors:
Stocks Rated by Nathan Weinstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVGN Evogene | Maintains: Buy | $100 → $80 | $1.14 | +6,917.54% | 2 | Sep 12, 2022 | |
| DRIO DarioHealth | Maintains: Buy | $400 → $300 | $13.27 | +2,160.74% | 6 | Aug 18, 2022 | |
| VNRX VolitionRx | Maintains: Buy | $9 → $6 | $0.61 | +891.74% | 5 | Aug 15, 2022 | |
| IMUX Immunic | Maintains: Buy | $40 → $35 | $0.94 | +3,626.97% | 2 | Aug 8, 2022 | |
| STXS Stereotaxis | Initiates: Buy | $6 | $2.94 | +104.08% | 1 | Jul 12, 2022 | |
| ORMP Oramed Pharmaceuticals | Maintains: Buy | $35 → $30 | $2.41 | +1,144.81% | 5 | May 16, 2022 | |
| TRVI Trevi Therapeutics | Initiates: Buy | $10 | $8.77 | +14.03% | 1 | Mar 29, 2022 | |
| MDWD MediWound | Maintains: Buy | $63 → $49 | $17.89 | +173.90% | 4 | Mar 21, 2022 | |
| ENVB Enveric Biosciences | Downgrades: Hold | $5,250 → $150 | $0.61 | +24,652.48% | 2 | Mar 8, 2022 | |
| CING Cingulate | Initiates: Buy | $2,160 | $3.81 | +56,592.91% | 1 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $120 | $2.64 | +4,445.45% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.31 | +663.36% | 2 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $160 | $90.50 | +76.81% | 2 | Sep 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $36.77 | +52.30% | 2 | Sep 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $27 | $5.27 | +412.33% | 3 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $1.08 | +3,155.81% | 4 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.82 | +559.34% | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $10.40 | +621.15% | 1 | Jan 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $104 → $88 | $2.82 | +3,020.57% | 3 | Oct 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $180 | $3.53 | +4,999.15% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $135 | $5.06 | +2,570.62% | 3 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $6.04 | +131.79% | 1 | Jul 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $220 | $16.00 | +1,275.00% | 7 | May 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8.5 | $3.40 | +150.00% | 1 | Mar 23, 2020 |
Evogene
Sep 12, 2022
Maintains: Buy
Price Target: $100 → $80
Current: $1.14
Upside: +6,917.54%
DarioHealth
Aug 18, 2022
Maintains: Buy
Price Target: $400 → $300
Current: $13.27
Upside: +2,160.74%
VolitionRx
Aug 15, 2022
Maintains: Buy
Price Target: $9 → $6
Current: $0.61
Upside: +891.74%
Immunic
Aug 8, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $0.94
Upside: +3,626.97%
Stereotaxis
Jul 12, 2022
Initiates: Buy
Price Target: $6
Current: $2.94
Upside: +104.08%
Oramed Pharmaceuticals
May 16, 2022
Maintains: Buy
Price Target: $35 → $30
Current: $2.41
Upside: +1,144.81%
Trevi Therapeutics
Mar 29, 2022
Initiates: Buy
Price Target: $10
Current: $8.77
Upside: +14.03%
MediWound
Mar 21, 2022
Maintains: Buy
Price Target: $63 → $49
Current: $17.89
Upside: +173.90%
Enveric Biosciences
Mar 8, 2022
Downgrades: Hold
Price Target: $5,250 → $150
Current: $0.61
Upside: +24,652.48%
Cingulate
Jan 11, 2022
Initiates: Buy
Price Target: $2,160
Current: $3.81
Upside: +56,592.91%
Dec 7, 2021
Initiates: Buy
Price Target: $120
Current: $2.64
Upside: +4,445.45%
Nov 1, 2021
Maintains: Buy
Price Target: $9 → $10
Current: $1.31
Upside: +663.36%
Sep 22, 2021
Maintains: Buy
Price Target: $180 → $160
Current: $90.50
Upside: +76.81%
Sep 9, 2021
Maintains: Buy
Price Target: $60 → $56
Current: $36.77
Upside: +52.30%
Aug 17, 2021
Maintains: Buy
Price Target: $26 → $27
Current: $5.27
Upside: +412.33%
Jun 7, 2021
Maintains: Buy
Price Target: $40 → $35
Current: $1.08
Upside: +3,155.81%
Mar 22, 2021
Initiates: Buy
Price Target: $12
Current: $1.82
Upside: +559.34%
Jan 26, 2021
Initiates: Buy
Price Target: $75
Current: $10.40
Upside: +621.15%
Oct 19, 2020
Maintains: Buy
Price Target: $104 → $88
Current: $2.82
Upside: +3,020.57%
Oct 8, 2020
Initiates: Buy
Price Target: $180
Current: $3.53
Upside: +4,999.15%
Aug 3, 2020
Maintains: Buy
Price Target: $195 → $135
Current: $5.06
Upside: +2,570.62%
Jul 13, 2020
Initiates: Buy
Price Target: $14
Current: $6.04
Upside: +131.79%
May 4, 2020
Maintains: Buy
Price Target: $180 → $220
Current: $16.00
Upside: +1,275.00%
Mar 23, 2020
Initiates: Buy
Price Target: $8.5
Current: $3.40
Upside: +150.00%